The major aim of the Blood Cell Foundation (BCF) is to support research and medical activities related to hematology and immunology, that is the treatment of diseases of the bone marrow and the immune system, including bone marrow transplantation. In this field the main objective of BCF is to help to introduce the results of related research into clinical practice. The Foundation also promotes preventive medicine, and spreading of related information in the general public.

BCF is a non-profit organization, with the goal to facilitate healthcare activities, including preventive, curative and rehabilitation efforts. The Foundation especially supports to obtain more detailed knowledge about the therapeutic effectiveness of haematopoietic stem cell transplantation and other stem cell based therapies. Therefore BCF focuses on the support of stem cell research, research in blood and bone marrow diseases. These provide the basis of the currently developing regenerative medicine, which may greatly increase the treatment possibilities in the diseases of blood, bone marrow, and the immune system. Furthermore, BCF supports inventions in specific diagnostics and therapy: research and development in molecular diagnostics, bone marrow transplantation, and gene therapy activities. These should also help the practice of bone marrow and cord blood stem cell transplantation, organ transplantation and transfusion therapies.

The future plans of BCF involve to support the establishment of a public cord blood bank in Hungary, which will preserve and store voluntarily donated cord blood units. Thus all patients requiring stem cell transplantation will be able to use this resource. Public cord blood banks are based on the recruitment of voluntary and altruistic donations. BCF supports the development of a Cord Blood Register in Hungary and the participation of this register in international exchange programs.

It is important to emphasize that in the bone marrow registries available throughout the world, it may be difficult to find appropriate donors for ethnic groups and minorities with uncommon HLA phenotype. Therefore BCF especially supports cord blood banking for such minorities. Although the number of registered donors increases, it becomes more and more difficult to increase the HLA diversity in the donor pool. Together with international, including EU activities, the Hungarian cord blood bank would offer a program to recruit new donors with rare or unique phenotype.

In Hungary and in the neighboring countries some ethnic populations are not represented in the general Registries, thus patients in ethnic minorities often do not have a suitable stem cell donor. The major aim of BCF and the Hungarian public donor bank is to establish these resources for the general public, including populations of ethnic minorities, via cord blood banking.